Prof. Sebahat Ocak discusses the 3-year overall survival data of the phase III, randomized controlled CASPIAN trial
Ariez Publishing
Prof. Sebahat Ocak discusses the 3-year overall survival data of the phase III, randomized controlled CASPIAN trial
00:00 / 07:43